Introduction
China has published a new mandatory baseline safety standard for cosmetics, giving brands, importers, private-label buyers and contract-manufacturing customers a long transition window—but also a substantial verification task.
GB 7916-2026, Cosmetics—General safety requirements, was published on July 30, 2026 and will take effect on January 1, 2028. The official national-standard record classifies it as mandatory. China’s State Administration for Market Regulation (SAMR) says the 1987 Cosmetics Hygiene Standard will be abolished when the new standard takes effect.
For buyers, the key point is not simply to ask a supplier whether it “complies with GB 7916.” The new baseline reaches across ingredients, finished products, packaging materials and carriers, labels, storage and transport. That makes readiness a supply-chain and documentation question as much as a laboratory-testing question.
This guide turns the official requirements into practical supplier-verification actions while keeping an important boundary clear: GB 7916-2026 is a China-market baseline. Products exported from China may also have to meet separate cosmetic, ingredient, labeling, safety-assessment and notification requirements in the destination market.
What changed—and why buyers should care
SAMR describes GB 7916-2026 as a mandatory national standard covering general cosmetic safety requirements, raw-material requirements and finished-product requirements. The regulator also highlights explicit requirements concerning packaging materials and carriers, labels, storage, transport and implementation.
The revision changes more than the standard number. According to SAMR, it adds terminology and definitions, improves general safety requirements, adds storage and transport requirements, and changes the lists of prohibited substances and prohibited plant and animal materials.
That combination matters to sourcing teams because a cosmetic product is not controlled only by its final formula. A product can create compliance or quality risk when a supplier changes a fragrance component, preservative source, botanical extract, packaging material, label statement, filling process or storage condition—even if the commercial product name remains unchanged.
The January 1, 2028 implementation date creates time to prepare, but buyers should not treat the transition as a reason to wait. Formula development, packaging qualification, stability work, safety assessment, registration or filing, artwork approval and production planning can all take significant time. Products intended to remain on the China market into 2028 should be reviewed well before the deadline.
1. Build an exact product-and-entity map
Start with the basics: identify exactly who owns the product responsibility and who performs each manufacturing step.
For every SKU, record the Chinese product name where applicable, product category, responsible registrant or filing entity, entrusted manufacturer, actual production site, filling or packing site, formula version, packaging configuration and current registration or filing status.
This prevents a common due-diligence mistake: reviewing a supplier at company level while the evidence actually belongs to a different factory, formula or product configuration.
If a brand uses an OEM or ODM supplier, ask whether formulation, bulk production, filling, packaging and release testing all occur at the same site. Where different entities are involved, document the relationship and determine which party controls specifications, changes and quality release.
2. Recheck ingredient controls against the new baseline
SAMR specifically says the revision changes prohibited-substance and prohibited plant/animal-material lists. Buyers should therefore ask suppliers how they are mapping current formulas and raw-material specifications against the 2026 standard.
Do not accept a generic statement such as “all ingredients are cosmetic grade.” Request the current formula or controlled ingredient list at the level appropriate to your commercial relationship, together with raw-material specifications, supplier information and safety documentation for ingredients that materially affect compliance or product safety.
For private-label products, establish whether the formula is fixed for your SKU or is a supplier platform formula used across multiple customers. If it is a shared formula, determine how the supplier controls future substitutions and whether the buyer will be notified before any ingredient source, concentration or composition change that could affect safety or compliance.
A useful verification question is: “Show us how you know the formula we approved today will still meet the applicable requirements when this batch is produced.” The answer should point to controlled specifications, approved suppliers, change-control procedures and documented review—not just experience or verbal assurance.
3. Verify raw-material supplier and incoming-control evidence
China’s existing cosmetics production rules already require quality-management systems and controls including supplier selection, raw-material acceptance, production and quality control, inspection and sample retention. GB 7916-2026 should be integrated into that operating system rather than treated as a stand-alone certificate.
Ask how critical raw materials are qualified and how incoming lots are checked. Depending on the ingredient and risk, evidence may include specifications, certificates of analysis, identity checks, microbiological or contaminant controls, supplier qualification records and incoming-inspection results.
For ingredients with complex compositions—such as botanical extracts, fragrances, colorants or functional blends—buyers should pay particular attention to whether the supplier understands the full material identity and any restricted or prohibited constituents relevant to the product.
Where the manufacturer relies on a raw-material distributor rather than the original producer, verify whether traceability remains sufficient to investigate a safety or quality issue back through the supply chain.
4. Treat packaging as part of the safety review
SAMR expressly identifies packaging materials and carriers within the new standard’s scope. This is a reminder that a safe formula can still be compromised by an unsuitable package.
Ask the supplier to define the approved primary-contact packaging for each SKU. Record material type, supplier, key specifications, closures, liners, pumps, droppers or other components that contact the cosmetic.
For relevant products, review compatibility and stability evidence rather than assuming that visually similar packaging is interchangeable. A change in resin, coating, ink, adhesive, liner or dispensing component may affect migration, leakage, product stability, dosage or contamination risk.
Include packaging in change control. If the factory wants to substitute a bottle, tube, jar, pump or liner because of cost or availability, require written review before production where the change could affect product safety, quality, labeling or consumer use.
5. Review labels against the exact product and market
The new standard explicitly includes label requirements, but buyers should avoid reducing label verification to a single GB 7916 checklist. China cosmetic labeling is governed by a wider regulatory framework, and product claims, ingredient declarations and required particulars should be reviewed against the complete current rules applicable to the product.
Operationally, control the artwork version. The label approved by regulatory or quality teams should be the same version released to the packaging supplier and used on the production line.
Before mass production, verify product identity, net content, ingredient information, responsible-party details, required warnings or directions, batch or date coding, and other mandatory particulars applicable to the SKU. For bilingual or export packaging, make sure added language does not create contradictory claims or obscure mandatory China-market information.
6. Add storage and transport to supplier qualification
SAMR highlights storage and transport as newly added areas in the revised standard. Buyers should therefore ask what conditions are necessary to preserve product safety and quality from factory release through warehousing and distribution.
Define any temperature, humidity, light, contamination or handling constraints that matter to the product. Then verify that the supplier’s warehouse and dispatch practices are compatible with those conditions.
For temperature-sensitive or stability-sensitive products, ask how excursions are handled and whether transport packaging is qualified for the expected route. A specification that works inside an air-conditioned factory is not enough if the finished goods may spend days in a hot container yard or uncontrolled warehouse.
Where a buyer controls international freight, the responsibility does not disappear at factory handover. Storage and transport requirements should be translated into logistics instructions and, where appropriate, monitored through the buyer’s forwarder or warehouse provider.
7. Link safety evidence to the exact production formula
A test report is only useful when it can be tied to what is actually manufactured.
Record the sample identity, formula version, batch or pilot-batch reference, packaging configuration, test date and laboratory. If the supplier presents historical reports, check whether the tested formula and packaging still match the proposed order.
Do the same for safety-assessment and registration or filing documentation where applicable. If an ingredient, concentration, source or packaging component changes, determine whether existing evidence remains valid or needs review.
Buyers should be particularly cautious with “family” reports or generic test packages that do not clearly identify the exact SKU. Similar product names do not prove identical formulations.
8. Strengthen change control before the deadline
The transition to January 2028 is an ideal time to formalize change control with suppliers.
Define which changes require buyer notification or approval. These can include formula composition, ingredient supplier, critical raw-material specification, fragrance or color system, manufacturing site, production process, primary packaging, label artwork, test method and storage condition.
Require the supplier to state what changed, why it changed, when it will enter production, what risk assessment was performed and what supporting evidence shows continued conformity.
For repeat orders, compare the current bill of materials, formula revision and packaging specification with the approved baseline. This reduces the risk that a product drifts away from the version originally reviewed.
9. Build a 2026–2027 transition file for each affected SKU
Rather than managing the standard as a single company-level project, create a transition record for each product or product family.
A practical file can include:
- Product and responsible-entity identification.
- Current formula and controlled ingredient list.
- Gap review against the new mandatory baseline.
- Raw-material and prohibited-material review status.
- Primary packaging specification and compatibility evidence.
- Current label/artwork version and review status.
- Safety-assessment, registration or filing references where applicable.
- Relevant test reports linked to the current formula.
- Storage and transport requirements.
- Open corrective actions and target dates.
- Supplier confirmation of change-control obligations.
Prioritize products with long development cycles, complex formulas, botanical or animal-derived materials, unusual packaging, high sales volume, planned 2028 China-market continuity or known supplier-change activity.
10. Questions buyers can send suppliers now
A focused supplier discussion can begin with these questions:
- Which of our current SKUs are intended to remain in production or sale in China after January 1, 2028?
- Who is responsible for the GB 7916-2026 gap assessment for each SKU?
- Has the current formula been checked against the revised prohibited-substance and prohibited plant/animal-material requirements?
- Which raw materials present the highest transition risk, and what evidence supports their continued use?
- Are the approved primary packaging materials and contact components documented and controlled?
- What label or artwork changes are expected before implementation?
- What storage and transport conditions are required for each product?
- Which existing tests, safety assessments, registrations or filings may need review if the formula or package changes?
- What changes can the factory make without buyer approval, and which require written notification?
- What is the supplier’s internal deadline for completing transition work before January 2028?
The goal is not to collect a stack of documents. It is to establish whether the supplier has a controlled plan connecting the legal requirement to the exact products the buyer purchases.
Limitations and uncertainty
GB 7916-2026 has been published but is not yet effective. The official record lists January 1, 2028 as the implementation date and SAMR states that the 1987 Cosmetics Hygiene Standard will be abolished at that time. Until implementation, companies must continue to follow the current applicable cosmetics regulatory framework while preparing for the new mandatory baseline.
The public official summary identifies the principal areas of change but does not substitute for a clause-by-clause review of the complete standard and all related cosmetics regulations and technical specifications. Product-specific obligations can vary by cosmetic category, formula, claim, responsible entity and route to market.
This article is therefore a buyer due-diligence guide, not a legal opinion or a complete compliance checklist. For products intended for the China market, regulatory teams should review the full standard and current NMPA/SAMR requirements. For exports, destination-market rules must be checked separately.
Conclusion
GB 7916-2026 gives cosmetics buyers a clear deadline and a useful reason to improve supplier controls before 2028. The strongest preparation is not a last-minute request for a certificate. It is a documented chain connecting the approved formula, raw materials, packaging, label, production site, test evidence, storage conditions and change-control process to the exact SKU being purchased.
Buyers that begin this work early can use the transition period to identify formula or packaging gaps, resolve evidence mismatches, update supplier agreements and avoid rushed changes close to the implementation date.
Sources / Research Notes
Primary official source: State Administration for Market Regulation (SAMR), “化妆品安全通用要求国家标准发布,” published August 6, 2026. SAMR states that GB 7916-2026 is a mandatory national standard, takes effect January 1, 2028, and covers general safety, raw materials, products, packaging materials/carriers, labels, storage and transport. It also identifies changes to prohibited-substance and prohibited plant/animal-material lists.
https://www.samr.gov.cn/xw/sj/art/2026/art_ff2c29f055af497e987edece5a639db4.html
Official national-standard record: GB 7916-2026, Cosmetics—General safety requirements. Published July 30, 2026; implementation January 1, 2028; status: pending implementation; competent authority and technical responsibility: National Medical Products Administration.
https://openstd.samr.gov.cn/bzgk/std/newGbInfo?hcno=FC110F762C7601FBFC5DBCCD9F5C6C85
Supporting regulatory context: Measures for the Supervision and Administration of Cosmetics Production and Operation. Existing rules require cosmetics producers to maintain quality-management systems and controls including supplier selection, raw-material acceptance, production and quality control, inspection and sample retention.
https://www.samr.gov.cn/zw/zfxxgk/fdzdgknr/fgs/art/2023/art_bb0c54e8c2374a5a9b4b0c8ddaf04e13.html
Internal traceability:
Research ID: SCC-RES-2026-016
Story ID: SCC-INS-2026-012
